Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-116299
Filing Date
2025-12-01
Accepted
2025-12-01 08:54:08
Documents
1
Period of Report
2025-11-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3071
  Complete submission text file 0001213900-25-116299.txt   4474
Mailing Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 (702) 514-4174
Pasithea Therapeutics Corp. (Issuer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 LINCOLN ROAD SUITE 500 MIAMI BEACH FL 33139
Business Address
Dumesnil Simon (Reporting) CIK: 0001875691 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40804 | Film No.: 251537369